Carina Rodriguez
Pediatric Infectious Diseases · Tampa, FLNPI 1013947654
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $1,860 of the $1,986 with a category attached, or 93.6%. Merck accounts for 95.4% of it on its own, with 1 other manufacturer making up the rest. Reporting peaked in 2024 at $1,860 and has fallen 97.2% since, to $52 in 2025.
Across 4 payments — averaging $496.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$2K
- Gilead$92
Across 442 payments — averaging $7008.19 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Modernatx, Inc.$2.7M
- Gilead$238K
- Genentech, Inc.$75K
- Viiv Healthcare Company$54K
- Merck$3K
What the payments were for
- Consulting fees$1,86094%
- Food & beverage$1266%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$1,986 in reported general payments places this provider in the 85th percentile of 41 pediatric infectious diseases providers in Florida.
See all pediatric infectious diseases providers in Florida →
Other pediatric infectious diseases in Tampa
- Claudia EspinosaTampa$75K
- Lisa SandersTampa$347
- David BermanSt Petersburg$48K
- Mobeen RathoreJacksonville$33K
- Ana AlvarezJacksonville$4K
- Gwendolyn ScottMiami$3K
- Pablo LauferMiami$2K
- Ivan GonzalezMiami$2K
- Manuel CotillaMiami$2K
- Robert ReidHollywood$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.